New Product Launch" DOXONIL"( November'21)

We are pleased to inform you that MEDICON Pharmaceuticals Ltd. is going to launch another exciting new product DOXONIL Tablet (400 mg) & Syrup (Doxofylline) to enrich our bronchodilator portfolio. Now it is available from 1st November 2021.

Doxofylline is a novel xanthine bronchodilator which shows better efficacy & less side effects during treatment of Asthma & COPD. It provides both bronchodilatory and anti-inflammatory action.